CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 174 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $36,000 | -36.8% | 14,750 | -6.2% | 0.00% | 0.0% |
| Q1 2017 | $57,000 | -33.7% | 15,725 | -35.2% | 0.00% | -50.0% |
| Q4 2016 | $86,000 | -12.2% | 24,275 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $98,000 | -8.4% | 24,275 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $107,000 | -55.2% | 24,275 | -61.6% | 0.00% | -25.0% |
| Q1 2016 | $239,000 | -75.9% | 63,275 | 0.0% | 0.00% | -78.9% |
| Q4 2015 | $992,000 | +48.7% | 63,275 | 0.0% | 0.02% | +58.3% |
| Q3 2015 | $667,000 | -58.2% | 63,275 | 0.0% | 0.01% | -58.6% |
| Q2 2015 | $1,596,000 | -9.5% | 63,275 | 0.0% | 0.03% | -6.5% |
| Q1 2015 | $1,763,000 | -7.6% | 63,275 | -39.4% | 0.03% | -3.1% |
| Q4 2014 | $1,907,000 | +30.8% | 104,475 | -7.1% | 0.03% | +28.0% |
| Q3 2014 | $1,458,000 | -47.4% | 112,520 | -33.7% | 0.02% | -46.8% |
| Q2 2014 | $2,771,000 | -7.7% | 169,820 | 0.0% | 0.05% | -11.3% |
| Q1 2014 | $3,001,000 | +43.6% | 169,820 | +96.8% | 0.05% | +43.2% |
| Q4 2013 | $2,090,000 | -8.4% | 86,310 | +34.1% | 0.04% | -15.9% |
| Q3 2013 | $2,281,000 | – | 64,385 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |